Key information
Duration
Start dates & application deadlines
- Starting August 2027
Application deadline not specified.
Language
English
TOEFL iBT: 80
Credits
90 SCH
Delivered
On Campus
Campus Location
Disciplines
Overview
The Ph.D. program in The University of Toledo's nationally ranked College of Pharmacy and Pharmaceutical Sciences focuses on Pharmacology and Experimental Therapeutics.
Features
- Learn about human disease — from the molecular level to the whole organism — and develop rational approaches for new pharmacological therapies.
- Our goal is for our doctoral students to translate their discoveries in the laboratory to therapies in a clinical setting.
Programme Structure
Curriculum:
- Experimental Therapeutics
- Current Topics in Toxicology
- Seminar in Experimental Therapeutics
- Current Topics in Pharmacokinetics Toxicokinetics
- Research Experience in Experimental Therapeutics
Admission requirements
Academic requirements
We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.
English requirements
TOEFL iBT: 80
Other requirements
General requirements
- Degree: Must hold a master’s degree from a regionally accredited college or university
- Application: UToledo application required
- GRE: Not Required. Highly recommended for international students.
- Transcripts: Required
- Statement of Purpose: Required
- Resume or CV: Required
- Letters of Recommendation: 3
Fees and funding
Tuition Fees
Tuition fees are shown in AUD and the most likely applicable fee is shown based on your nationality.
- International: 39,749 AUD / year (≈ 28,306 USD / year)
- Out-of-State: 39,749 AUD / year (≈ 28,306 USD / year)
- Domestic / In-State: 22,651 AUD / year (≈ 16,130 USD / year)
Living costs
Toledo, United States: 1,254-2,068 AUD / month
The living costs include the total expenses per month, covering accommodation, public transportation, utilities (electricity, internet), books and groceries.
Funding
Scholarships: Below you will find PhD's scholarship opportunities for Experimental Therapeutics.